Literature DB >> 5705181

The release of platelet factor 4 during platelet aggregation and the possible significance of this reaction in hemostasis.

S Niewiarowski, B Lipiński, R Farbiszewski, A Poplawski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5705181     DOI: 10.1007/bf02140810

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  8 in total

1.  METHOD FOR DETERMINING ANTIHEPARIN ACTIVITY OF PLATELETS AND ERYTHROCYTES.

Authors:  A POPLAWSKI; S NIEWIAROWSKI
Journal:  Thromb Diath Haemorrh       Date:  1965-03-15

2.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

3.  Significance of clotting factors in blood-platelets, in normal and pathological conditions.

Authors:  S van CREVOLD; M M P PAULSSEN
Journal:  Lancet       Date:  1951-08-11       Impact factor: 79.321

4.  Changes in platelet volume produced by temperature, metabolic inhibitors, and aggregating agents.

Authors:  B S Bull; M B Zucker
Journal:  Proc Soc Exp Biol Med       Date:  1965-11

5.  Neutralization of antithrombin VI (fibrinogen breakdown products) with platelet antiheparin factor (platelet factor 4).

Authors:  S Niewiarowski; R Farbiszewski; A Poplawski
Journal:  Thromb Diath Haemorrh       Date:  1965-11-15

6.  Platelet aggregation during fibrin polymerization.

Authors:  N O Solum
Journal:  Scand J Clin Lab Invest       Date:  1966       Impact factor: 1.713

7.  Modification of the electrokinetic response of blood platelets to aggregating agents.

Authors:  J R Hampton; J R Mitchell
Journal:  Nature       Date:  1966-06-04       Impact factor: 49.962

8.  Secondary clumping effect in human citrated platelet-rich plasma produced by adenosine diphosphate and adrenaline.

Authors:  D C Macmillan
Journal:  Nature       Date:  1966-07-09       Impact factor: 49.962

  8 in total
  7 in total

1.  Ultrastructural studies of the gray platelet syndrome.

Authors:  J G White
Journal:  Am J Pathol       Date:  1979-05       Impact factor: 4.307

2.  Physiopathology of cellular peptides.

Authors:  R Keller
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

3.  The activity of platelet factor 4 in plasma of healthy and high risk newborns.

Authors:  M Alebouyeh; W Unterharnscheidt; K Riegel
Journal:  Z Kinderheilkd       Date:  1974-01-17

4.  Thrombosis and embolism after injury.

Authors:  S Sevitt
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1970

5.  Inhibition by aspirin of release of antiheparin activity from human platelets.

Authors:  A H Youssef; P Barkhan
Journal:  Br Med J       Date:  1969-08-16

6.  Modification of human platelet behaviour in diabetes.

Authors:  E Roux; N Romquin; M Laurent; F Regnault
Journal:  Acta Diabetol Lat       Date:  1977 Sep-Dec

7.  Platelet and coagulation factors in proliferative diabetic retinopathy.

Authors:  D Q Borsey; C V Prowse; R S Gray; J Dawes; K James; R A Elton; B F Clarke
Journal:  J Clin Pathol       Date:  1984-06       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.